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ABSTRACT
Objective: Nowadays, there is an increased incidence of infertility in Indian males due to lifestyle changes. Hence, the objective of this study is 
evaluating the gonadotropin releasing hormones (GnRH) level in infertile young male in Indian population.
Materials and Methods: In total, 56 patients having abnormal semen count and five control patients have been included in the study. All patients 
were underwent sperm count and estimation of hormones includes GnRH such as follicle stimulating hormone (FSH), tri-iodothyronine, thyroxin, 
prolactin, and testosterone.
Results: The sperm concentration of infertile men was significantly lower than control. Sperm motility behaviors rapid, sluggish, and non-motile 
characters were significantly lower than control. Among GnRH, FSH has been significantly higher in infertile group than control group.
Conclusion: FSH may be considered as a marker for male infertility.
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INTRODUCTION
Infertility is a worldwide problem and it affects 15% of married couples 
worldwide [1]. The prevalence of infertility in the general population is 
15-20%, and of this, the male factor is responsible for 20-40% [2,3], and 
in India, the prevalence is around 23% [4]. In a preliminary study by 
the World Health Organization multi-center study, 45% of infertile men 
were found to be affected by oligozoospermia or azoospermia [5-7]. 
The semen analysis is initially assessed and if it is found abnormal 
(especially if sperm concentration is <15 million per milliliter) [8] then 
the sample is subjected for further analysis to ascertain the possibilities 
of hormonal disorders or imbalance. The patients with such abnormal 
sperm count are recommended to undertake a blood hormonal test 
as these hormonal tests are found to be reliable and accurate [9]. 
Men produce both, male hormones (testosterone) as well as pituitary 
hormones such as follicle stimulating hormone (FSH) and luteinizing 
hormone (LH) which are among the gonadotropin releasing hormones 
(GnRH) [10]. Blood tests for testosterone and FSH levels are usually taken 
initially and if the testosterone levels are low, then LH is measured [11]. 
Low levels of FSH, LH, and testosterone may indicate a diagnosis of 
hypogonadotropic hypogonadism [12,13], and a very high FSH levels 
(compared to normal levels of other hormones) indicate abnormalities 
in initial sperm production [10]. In India, the prevalence of infertility in 
men is increasing steadily and it has reached to such alarming levels that 
its incidence may affect the male population in future. The incidence 
cannot be ignored, therefore a detailed study involving the sperm count 
and hormonal profile especially FSH, LH, and testosterone concentration 
is an urgent necessity to ascertain the fertility problems in men [14]. 
Unfortunately, this study is poorly documented in India; therefore, this 
study can be considered as a step toward evaluating the GnRH level in 
infertile young male in Indian population.
METHODS
The study involved analysis of primary health records of around 
56 patients (aged above 32) having abnormal semen count. The 
sample also included 5 controls comprising healthy volunteers. This 
study has been approved by hospital ethics committee. The clinical 
examination and the lifestyle of each individual were collected 
which comprised their age, health problems, food habit, duration of 
marriage, and history of infertility in the family. The semen samples 
were collected from the infertile subjects after a prerequisite of 
2-7 days of sexual abstinence. Estimation of sperm counting was 
done using the Meckler’s chamber, and morphology study was based 
on the smear diff quick stain method. Sperm analysis was performed 
according to the World Health Organization guidelines. Based on 
the sperm concentration, the infertile subjects were classified into 
normozoospermia (>15 million sperm/ml), oligoasthenozoospermia 
A+B (≥32 million sperm/ml), and azoospermia (no spermatozoa) 
wherein in fertile controls, the sperm count ranged from 15 to 
120 million sperms/ml. The scrotal Doppler test was done and the 
grade of varicoceles was recorded. Testicular biopsy was carried out 
to understand the histopathological condition of the samples. The 
serum tri-iodothyronine (T3) and thyroxin (T4), thyroid stimulating 
hormone (TSH), LH, FSH, Prolactin, and Testosterone levels in all 
the samples including control were collected and analyzed. The 
hormonal assays was done by Chemi luminescence method using the 
kits supplied by Diagnostic Products Corporation; USA. The data were 
analyzed using Medcalc statistical software. The mean t-test was done 
to understand the significance of the study.
RESULTS AND DISCUSSION
The mean sperm concentration in infertile males (33.52±30.50) was 
found to be very low compared to fertile controls (73.7±36.39) which 
relates to its abnormal nature. Among the data, the values having mean 
t-test with p value (<0.05) were considered for analysis. Here, it is noted 
that the sperm concentration is directly proportional to the high value 
of normal counts compared to the abnormal counts so that we can 
easily predict the sperm concentration based on the given statistical 
data in the study (Fig. 1).
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Observation of the sperm motility behaviors such as rapid (A), sluggish 
(B), twitching (C), and non-motile (D) in infertile males showed 
that there was a significant decrease in rapid (5.73±4.90; normal: 
10.0±5.45), sluggish (29.64±14.76; normal: 40.4±6.8) and non-motility 
(52.41±17.92; normal: 38.1±8.96) behavior, but there was insignificant 
changes in twitching (12.20±6.97; normal: 11.5±4.6) behavior of the 
sperms compared to control. The analysis states that the rapid and 
sluggish behaviour of the sperms in abnormal conditions are good 
indicators of infertility in males (Fig. 2). The p value of mean t-test had 
the sperm motility in the range of p<0.05 in abnormal conditions.
Sperm morphology is the criteria for males having successful 
fertilization. While considering the sperm morphological characters 
such as normal form (NF), head defect (HD), neck defect (ND), 
cytoplasmic droplet (CD), tail defect (TD) in infertile males, the ND 
(4.62±2.71; normal: 20.5±5.16) range was significantly very low, CD 
(4.62±2.71; normal: 5.6±3.47) and TD (1.1±0.87; normal: 0.83±0.77) 
level did not show significant difference, NF (2.05±0.99; normal level: 
6.5±2.2) level too was less, but HD (76.48±7.78; normal:66.3±5.37) level 
was significantly higher than normal. It is a known fact that the head 
is more important part of the sperm, wherein the defects are clearly 
seen in abnormal patients (males) (Fig. 3). The p value of mean t-test 
had p<0.0001, 0.0050, <0.0001, in normal samples and the abnormal 
patients had low p<0.05 comparatively, which is quite significant.
Among the infertile men 19.0% had azoospermia, 56% had 
asthenozoospermia, 3.56% had teratozoospermia, 8.14% had 
asthenoteratozoospermia, 14.25% had oligoteratozoospermia, 
10 5.70% had oligoasthenoteratozoospermia, 11.40% had severe 
oligoasthenoteratozoospermia, and 11.40% had normozoospermia. 
In the infertile men, higher concentration of FSH is considered to be a 
reliable indicator of germinal epithelial damage and was shown to be 
associated with azoospermia and severe oligozoospermia [15].
The GNRH such as LH, FSH, TSH, T3, T4, prolactin, and testosterone is 
the major contribution of this study. The results of GnRH such as T3, T4, 
TSH, LH, FSH, prolactin, and testosterone levels in infertile and control 
(proven fertile men) groups are analyzed (Table 1) and it is found 
that T3 (3.52±0.41; normal value: 3.68±0.66), T4 (1.33±0.14; normal: 
1.29±0.26), TSH (2.99±1.34; normal: 2.92±1.94), LH (5.93±2.31; 
normal: 7.22±4.30), and testosterone levels (3.27±0.85; normal: 
3.55±1.96) were insignificantly conspicuous when compared to FSH 
(4.02±1.65; normal:19.64±8.89), and prolactin (10.45±4.73; normal: 
13.15±11.42). FSH and LH levels were significantly elevated in infertile 
males when compared with fertile males (control).
The impressions such as T3, T4, TSH, LH, prolactin, and testosterone 
had a low variation, but the FSH value was highly significant in 
the normal compared to abnormal values. FSH, LH, TSH, T3, T4, 
prolactin, and testosterone evaluation are useful in the management 
of male infertility [9]; FSH maintains the sperm production and the LH 
stimulates the production of the hormone testosterone. For initiation of 
spermatogenesis and maturation of spermatozoa, FSH is necessary. In the 
infertile men, higher concentration of FSH is considered to be a reliable 
indicator of germinal epithelial damage and was shown to be associated 
with azoospermia and severe oligoasthenoteratozoospermia [16] (Fig. 4).
The mean “t” test has been carried out for the all hormones (including 
p value) for T3, T4, TSH, FSH, LH, prolactin, and testosterone and their 
Fig. 2: Diagrammatic representation of motility test in normal 
and abnormal sperms in male samples
Fig. 4: Diagrammatic representation of hormonal study 
comparing normal and abnormal patients
Fig. 1: Comparative diagram depicting the sperm concentration in 
normal and abnormal male (≤32 age) Fig. 3: Diagrammatic representation of morphological differences 
in normal and abnormal sperms in males
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levels were 0.4665, 0.6405, 0.9142, <0.0001, 0.3638, 0.4686, 0.6615, 
respectively. In this study, the FSH showed a significant increase 
(p<0.05) in the male young infertile groups (i.e., >32 year). Elevated 
levels of serum FSH with increasing severity of seminiferous epithelial 
destruction is also reported [10-12,17,18], which showed elevated 
levels of both FSH and LH in infertile males. Elevated levels of LH in 
oligozoospermia and azoospermia males when compared to normal 
fertile men were also reported [9,12] in similar studies. The differences 
in the mean serum testosterone levels between fertile and infertile 
men were insignificant. Similar observations were made [17,18]. FSH, 
LH, and testosterone are prime regulators of germ cell development. 
The quantitative production of spermatozoa generally requires 
the presence of FSH, LH and testosterone. FSH acts directly on the 
seminiferous tubules whereas LH stimulates spermatogenesis 
indirectly via testosterone. FSH also plays a key role in stimulating 
mitotic and meiotic DNA synthesis in spermatogonia [19]. This study 
found significantly lower total sperm counts and sperm morphologies, 
which contradicted with lower free testosterone level and high FSH 
levels which were significant.
All the subjects were normal individuals and their chromosome analysis 
did not present any evidence for abnormal karyotypes. In addition, 
there is no family history of infertility in the cases studied, and hence 
the infertility in these cases might be attributed to hormonal causes. 
The overall results clearly indicate significant increase in gonadotropins 
(FSH and LH) in all the subgroups (azoospermia, oligozoospermia, 
and varicoceles) and also in infertile males with abnormal testicular 
histology. Although there was no significant decrease in the testosterone 
levels in infertile males when compared with the fertile controls, 
the increase in the levels of gonadotropins might have disrupted the 
spermatogenic process leading to the decline in the sperm count and 
infertility. The importance of FSH action on sperm production has 
long been a matter of debate. The clinical and experimental data, thus 
generated in this study support a theoretical paradigm in which FSH 
exerts stimulatory effects on both the quantitative and qualitative 
aspects of testosterone driven spermatogenesis.
In conclusion, FSH may be a useful biomarker for diagnosis of infertility 
in young male population. Further in depth studies are required to 
confirm our results. More similar studies in the future may bring out a 
better picture related to FSH and infertility.
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Table 1: Comparative charts depicting the various parameters 
adopted to characterize the normal and abnormal sperm levels 
in values along with their significances
Parameters Normal Abnormal p value
Age years 29±1.88 28.97±1.68 NS
Abtinance 3.5±0.70 4.36±0.31 NS
Volume (ml) 2.05±0.76 2.53±1.28 NS
pH 8 7.9±0.14 NS
SP. count (M/ml) 73.7±36.39 33.52±30.50 <0.0001
Motility
Rapid (A) 10±5.45 5.73±4.90 <0.0001
Sluggish (B) 40.4±6.8 29.64±14.76 <0.0001
Twitching (C) 11.5±4.6 12.20±6.97 NS
Immotile (D) 38.1±8.96 52.41±17.92 <0.0001
Morphology
NF 6.5±2.2 2.05±0.99 <0.0001
HD 66.3±5.37 76.48±7.78 0.0050
ND 20.5±5.16 4.62±2.71 <0.0001
CD 5.6±3.47 4.62±2.71 NS
TD 1.1±0.87 0.83±0.77 NS
Hormone value
T3 3.52±0.41 3.68±0.66 0.4665
T4 1.33±0.14 1.29±0.26 0.6405
TSH 2.99±1.34 2.92±1.94 0.9142
FSH 4.02±1.65 19.64±8.89 <0.0001
LH 5.93±2.31 7.22±4.30 0.3638
Prolactin 10.45±4.73 13.15±11.42 0.4686
Testosterone 3.27±0.85 3.55±1.96 0.6615
NS: Statistically not significant, NF: Normal form, HD: Head defect, ND: Neck 
defect, CD: Cytoplasmic droplet, TD: Tail defect, FSH: Follicle stimulating 
hormone, T3: Tri-iodothyronine, T4: Thyroxin, TSH: Thyroid stimulating 
hormone, LH: Luteinizing hormone
